Vaccine Contract Manufacturing Market Influenced by Strategic Expansion of Standalone Manufacturing Facilities
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Is The Market Size Of The Vaccine Contract Manufacturing Market Expected To Scale Between 2026 And 2030?
The vaccine contract manufacturing market has demonstrated strong expansion in recent years. This market is projected to increase from $3.88 billion in 2025 to $4.27 billion in 2026, at a compound annual growth rate (CAGR) of 10.0%. The growth observed in the historic period can be attributed to the broadening of global immunization programs, the escalating complexity of vaccine production processes, an increased reliance on specialized contract manufacturers, the rise of public-private vaccine partnerships, and the establishment of substantial vaccine manufacturing facilities.
The vaccine contract manufacturing market is projected for substantial expansion in the coming years, reaching a valuation of $6.46 billion by 2030, driven by a compound annual growth rate (CAGR) of 10.9%. This anticipated growth during the forecast period stems from factors such as an escalating need for swift vaccine production scaling, heightened capital allocation towards mRNA and innovative vaccine types, the broadening of commercial manufacturing operations, an increasing emphasis on achieving regional vaccine independence, and the integration of cutting-edge bioprocess technologies. Key trends anticipated within the same forecast timeframe encompass a growing reliance on external providers for vaccine manufacturing, a heightened requirement for adaptable production capacities, the broadening of fill-finish service offerings, an intensifying focus on production adhering to regulatory standards, and a wider embrace of single-use bioprocessing solutions.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12216&type=smp
Which Drivers Are Supporting The Vaccine Contract Manufacturing Market Growth?
The global increase in infectious diseases is anticipated to accelerate the expansion of the vaccine contract manufacturing market. These disorders originate from pathogenic microorganisms such as bacteria, viruses, fungi, or parasites. When outbreaks occur, involving conditions like influenza, measles, or new viruses, an urgent requirement for vaccines emerges to prevent wider dissemination. Contract manufacturers are well-positioned to swiftly escalate production in response to these situations. For instance, in October 2024, the World Health Organization, an international public health organization based in Switzerland, reported that approximately 8.2 million people were newly diagnosed with tuberculosis in 2023. This marked an increase from about 7.5 million in 2022, establishing tuberculosis as the leading infectious disease killer. Hence, the growing prevalence of infectious diseases worldwide is a key factor driving the growth of the vaccine contract manufacturing market.
How Is The Vaccine Contract Manufacturing Market Broken Down By Segment Categories?
The vaccine contract manufacturing market covered in this report is segmented –
1) By Service Type: Fill-Finish, Bulk Product
2) By Vaccine Type: Inactivated Vaccines, Live-Attenuated Vaccines, RNA (Ribonucleic Acid) Vaccines, Subunit Vaccines, Toxoid-Based Vaccines
3) By Process: Downstream, Upstream
4) By Scale Of Operation: Preclinical, Clinical, Commercial
5) By End-Use: Human Use, Veterinary
Subsegments:
1) By Fill-Finish: Aseptic Fill-Finish, Lyophilization, Vial Filling, Syringe Filling
2) By Bulk Product: Cell Culture, Microbial Fermentation, Antigen Production, Buffer Preparation
Which Trends Are Expected To Impact The Vaccine Contract Manufacturing Market?
Key companies in the vaccine contract manufacturing market are strategically focusing on establishing new production sites to secure their market presence. The opening of a production site for vaccine contract manufacturing involves setting up a facility specifically designed for the contractual manufacturing and production of vaccines. For example, in September 2023, WuXi Vaccines, a China-based contract development and manufacturing organization (CDMO) specializing in vaccine discovery and production, opened its first dedicated vaccine CDMO facility in Suzhou, China. This expansion signifies a major achievement for the company, bringing about increased capabilities for both drug substance and drug product manufacturing. WuXi Vaccines now delivers an extensive array of services for various vaccines, including process development, drug product development, and the production of clinical-scale drug substances (DS) and small-to-medium sterile drug products (DP). The new standalone site strengthens WuXi Vaccines’ ability to contribute to vaccine development and manufacturing, playing a key role in advancing global healthcare solutions.
Which Players Are Present In The Vaccine Contract Manufacturing Market Space?
Major companies operating in the vaccine contract manufacturing market are Pfizer Inc, Johnson & Johnson, AbbVie Inc., Sanofi, GlaxoSmithKline, Merck KGaA, Moderna, BioNTech, GSK Vaccines, AstraZeneca PLC, Ajinomoto Co. Inc., Lonza Group AG, Catalent Inc., Charles River Laboratories International Inc., Serum Institute of India Pvt. Ltd, Samsung Biologics, WuXi Biologics, Novavax, Sinovac Biotech, Emergent BioSolutions Inc., Bio Farma, Hualan Biological Engineering, BioMARC, Bavarian Nordic A/S, AGC Biologics, IDT Biologika GmbH, Bharat Biotech, Goodwin Biotechnology Inc., Biofabri S.L
Get The Full Vaccine Contract Manufacturing Market Report:
Which Geographic Region Dominates The Vaccine Contract Manufacturing Market?
North America was the largest region in the vaccine contract manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the vaccine contract manufacturing market report forecast period. The regions covered in the vaccine contract manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Vaccine Contract Manufacturing Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Vaccine Contract Manufacturing Market 2026, By The Business Research Company
Antibody Contract Manufacturing Market Report 2026
Biopharmaceuticals Contract Manufacturing Market Report
Vaccines Market Report
https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
